Insomnia affects approximately 30% of adults at some point in their lives, making it one of the most common sleep complaints seen in psychiatric practice. As a sleep-related disorder with deep connections to mental health, insomnia involves persistent difficulty falling asleep, staying asleep, or waking too early — despite adequate opportunity for rest. At Elevate Psychiatry, we treat insomnia as both a standalone condition and a frequent companion to anxiety, depression, PTSD, and other psychiatric disorders.
Chronic insomnia — defined as sleep difficulties occurring at least three nights per week for three months or longer — can significantly impair daytime functioning, mood regulation, cognitive performance, and overall quality of life. Research consistently shows that untreated insomnia increases the risk of developing major depression by up to fourfold and worsens outcomes in nearly every psychiatric condition.
Insomnia is broadly classified into two categories. Primary insomnia occurs independently of other medical or psychiatric conditions and is often driven by hyperarousal — a state where the nervous system remains overly activated at bedtime. Secondary or comorbid insomnia develops alongside conditions like generalized anxiety disorder, depression, chronic pain, or substance use. In clinical practice, distinguishing between these types helps guide treatment selection.
Acute insomnia, lasting days to weeks, often follows stressful life events — job changes, relationship difficulties, or health concerns. While acute episodes frequently resolve on their own, they can transition into chronic insomnia if maladaptive sleep behaviors develop, such as excessive time in bed, inconsistent sleep schedules, or reliance on alcohol or over-the-counter sleep aids.
Modern insomnia treatment has moved well beyond simply prescribing sleeping pills. The American Academy of Sleep Medicine and the American College of Physicians both recommend Cognitive Behavioral Therapy for Insomnia (CBT-I) as the first-line treatment for chronic insomnia in adults. CBT-I addresses the thoughts, behaviors, and habits that perpetuate sleep difficulties without the side effects or dependency risks associated with medications.
CBT-I typically includes several components: sleep restriction therapy (limiting time in bed to match actual sleep time), stimulus control (re-associating the bed with sleep rather than wakefulness), cognitive restructuring (challenging unhelpful beliefs about sleep), sleep hygiene education, and relaxation training. Most patients see significant improvement within four to eight sessions, and the benefits tend to be more durable than those achieved with medication alone.
When behavioral approaches alone are insufficient, psychiatric medication management can play an important role. Several classes of medications are used for insomnia, each with distinct mechanisms and risk profiles. Trazodone, prescribed at low doses, remains one of the most commonly used off-label sleep aids due to its sedating properties and low abuse potential. Hydroxyzine is another option that can address both anxiety and sleep difficulties.
Newer medications like suvorexant (Belsomra) and lemborexant (Dayvigo) work by blocking orexin receptors that promote wakefulness, offering a different approach than traditional sedative-hypnotics. Gabapentin may be prescribed when insomnia co-occurs with anxiety or neuropathic pain. Your psychiatrist at Elevate Psychiatry will evaluate your complete clinical picture — including any co-occurring conditions, current medications, and treatment history — to recommend the most appropriate medication strategy.
Insomnia rarely exists in isolation. It frequently co-occurs with and can be an early warning sign of mood disorders, anxiety disorders, PTSD, and substance use disorders. Persistent early-morning awakening, for example, is a hallmark of depression, while difficulty falling asleep often accompanies anxiety. Sleep disruption is also one of the earliest symptoms of a developing manic episode.
A thorough psychiatric evaluation helps identify whether insomnia is the primary problem or a symptom of an underlying condition that requires its own treatment. At Elevate Psychiatry, our comprehensive assessments explore sleep patterns, mental health history, substance use, medical conditions, and medication effects to develop a targeted treatment plan.
Living with chronic insomnia takes a measurable toll on your mental health, relationships, work performance, and physical wellbeing. Effective treatments exist, and most patients experience meaningful improvement within weeks of starting the right approach. Schedule an appointment with Elevate Psychiatry to discuss your sleep difficulties and explore treatment options that fit your needs. We offer both in-person appointments at our Miami locations and virtual visits throughout Florida.
Building strong sleep habits is fundamental to overcoming insomnia. Explore our complete guide to sleep hygiene for practical strategies that improve sleep quality and mental health.
Trazodone is one of the most commonly prescribed sleep medications. Read our detailed guide on trazodone for sleep to understand dosing, benefits, and side effects.
For treatment-resistant insomnia, low-dose Seroquel (quetiapine) is sometimes prescribed — particularly when insomnia co-occurs with bipolar disorder or severe anxiety.
This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
